Table 4. Multivariate analysis of the risk factors for the incidence of adverse signs in the128 patients who underwent the OGTT.
| Adverse signs | OR (CI 95%)* | p | ||
|---|---|---|---|---|
|
| ||||
| Yes | No | |||
| Gender | ||||
| Female | 32 | 85 | 3.52 (0.39-31.8) | 0.26 |
| Male | 1 | 10 | 1.0 | |
| Age (years) | ||||
| < 40 | 21 | 62 | 1.0 | 0.94 |
| ≥ 40 | 12 | 33 | 0.96 (0.36-2.59) | |
| Postoperative time | ||||
| < 3 years | 12 | 34 | 1.0 | 0.40 |
| ≥ 3 year | 21 | 61 | 0.67 (0.26-1.74) | |
| History of arterial hypertension | ||||
| No | 23 | 83 | 1.0 | 0.03 |
| Yes | 10 | 12 | 3.64 (1.17-11.34) | |
| Hypoglycemia | ||||
| No | 22 | 87 | 1.0 | 0.00 |
| Yes | 11 | 8 | 8.14 (2.63-25.12) | |
* Adjusted for all sociodemographic and clinical variables.